Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer. | Front Immunol | 2023 | 37771596 | PubTator, text mining | PubMed |
| Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems. | Pharmaceutics | 2023 | 37765331 | PubTator, text mining | PubMed |
| SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer. | Int J Mol Sci | 2023 | 37762518 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Source of Biomarkers in Glomerulonephritis. | Int J Mol Sci | 2023 | 37762196 | PubTator, text mining | PubMed |
| Advances in Histological and Molecular Classification of Hepatocellular Carcinoma. | Biomedicines | 2023 | 37761023 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Profiling of Young Breast Cancer Patients Reveals a Correlation between Galactose Metabolism Pathway and Poor Disease-Free Survival. | Cancers (Basel) | 2023 | 37760606 | PubTator, text mining | PubMed |
| Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma. | Cells | 2023 | 37759483 | PubTator, text mining | PubMed |
| Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer. | NPJ Breast Cancer | 2023 | 37758711 | PubTator, text mining | PubMed |
| ERBB2-Mutant Gastrointestinal Tumors Represent Heterogeneous Molecular Biology, Particularly in Microsatellite Instability, Tumor Mutation Burden, and Co-Mutated Genes: An In Silico Study. | Curr Issues Mol Biol | 2023 | 37754252 | PubTator, text mining | PubMed |
| HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. | Curr Issues Mol Biol | 2023 | 37754227 | PubTator, text mining | PubMed |
| The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective. | Front Immunol | 2023 | 37753089 | PubTator, text mining | PubMed |
| Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. | Nat Commun | 2023 | 37749078 | PubTator, text mining | PubMed |
| Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. | World J Gastrointest Oncol | 2023 | 37746645 | PubTator, text mining | PubMed |
| Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications. | Front Physiol | 2023 | 37745252 | PubTator, text mining | PubMed |
| Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer. | Technol Cancer Res Treat | 2023 | 37743841 | PubTator, text mining | PubMed |
| Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients. | Endocrinol Diabetes Metab | 2023 | 37743677 | PubTator, text mining | PubMed |
| SL-scan identifies synthetic lethal interactions in cancer using metabolic networks. | Sci Rep | 2023 | 37737478 | PubTator, text mining | PubMed |
| Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses. | J Cancer Res Clin Oncol | 2023 | 37736788 | PubTator, text mining | PubMed |
| Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer. | J Transl Med | 2023 | 37735483 | PubTator, text mining | PubMed |
| Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma. | Aging (Albany NY) | 2023 | 37728407 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=22